Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-02-06T10:53:41.083Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Trial with Trinuride

Published online by Cambridge University Press:  08 February 2018

D. S. Sharpe ,
G. Dutton  and
J. R. Mirrey
D. S. Sharpe
Affiliation:
Botleys Park Hospital, Chertsey
G. Dutton
Affiliation:
Botleys Park Hospital, Chertsey
J. R. Mirrey
Affiliation:
Botleys Park Hospital, Chertsey
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Spielman and his colleagues (1948) were initially responsible for demonstrating the anti-convulsant action of the acetylurea derivatives. However, it was not until several years later that comprehensive studies were carried out by Professor Frommel in Geneva (1953).

Type
Original Articles
Information
Journal of Mental Science , Volume 104 , Issue 436 , July 1958 , pp. 834 - 839
Copyright
Copyright © Royal College of Psychiatrists, 1958 

References

Frommel, E., et al., Arch. Int. Pharmacodym., 1953, 92, 368.Google Scholar
Idem , personal communication.Google Scholar
Krauss, S., personal communication.Google Scholar
Ruggeri, R. L. D., and de Sanctis, T., Riv. sper. Freniat., 1952, 764.Google Scholar
Sorel, L., and de Smedt, R., Acta. Neurol. Psychiat. Belg., 1953, 8, 531.Google Scholar
Soyter, E. von and Fässler, J., Schweiz. Med. Wschr., 1956, 34, 956.Google Scholar
Spielman, M. A., Geisler, A. O., and Close, W. J., “Anti-convulsant drugs”, J. Amer. Chem. Soc., 1948, 70, 4189–4198.Google Scholar
Walter, S., Praxis, 1951, 51, 1954.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.